company background image
3692 logo

Hansoh Pharmaceutical Group SEHK:3692 Stok Raporu

Son Fiyat

HK$17.86

Piyasa Değeri

HK$101.8b

7D

4.3%

1Y

22.8%

Güncellenmiş

20 Nov, 2024

Veri

Şirket Finansalları +

Hansoh Pharmaceutical Group Company Limited

SEHK:3692 Stok Raporu

Piyasa değeri: HK$101.8b

3692 Stoklara Genel Bakış

Bir yatırım holding şirketi olan Hansoh Pharmaceutical Group Company Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünlerin araştırılması, geliştirilmesi, üretimi ve satışı ile ilgilenmektedir. Daha fazla detay

Hansoh Pharmaceutical Group Company Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Hansoh Pharmaceutical Group
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$17.86
52 Haftanın En Yüksek SeviyesiHK$22.80
52 Haftanın En Düşük SeviyesiHK$11.18
Beta0.65
11 Aylık Değişim-15.75%
3 Aylık Değişim-3.56%
1 Yıllık Değişim22.83%
33 Yıllık Değişim2.88%
5 Yıllık Değişim-28.13%
Halka arzdan bu yana değişim-8.41%

Son Haberler & Güncellemeler

Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Nov 04
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Recent updates

Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Nov 04
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Aug 28
Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now

Aug 07
Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now

If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity

Jul 16
If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 06
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year

Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

May 23
Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 01
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Mar 28
Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

Mar 04
There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Feb 16
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Dec 08
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Oct 12
Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Sep 14
Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 10
Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jan 23
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Dec 01
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Oct 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Aug 28
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Jun 09
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

May 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

Apr 22
Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Feb 06
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Hissedar Getirileri

3692HK PharmaceuticalsHK Pazar
7D4.3%-2.1%0.05%
1Y22.8%-9.4%11.5%

Getiri vs. Endüstri: 3692 geçen yıl % -9.4 oranında getiri sağlayan Hong Kong Pharmaceuticals sektörünü aştı.

Getiri vs Piyasa: 3692 geçen yıl % 11.5 oranında getiri sağlayan Hong Kong Piyasasını aştı.

Fiyat Oynaklığı

Is 3692's price volatile compared to industry and market?
3692 volatility
3692 Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market18.9%
10% least volatile stocks in HK Market4.2%

İstikrarlı Hisse Senedi Fiyatı: 3692 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 3692 'nin haftalık oynaklığı ( 8% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
19959,099Huijuan Zhongwww.hspharm.com

Bir yatırım holding şirketi olan Hansoh Pharmaceutical Group Company Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünlerin araştırılması, geliştirilmesi, üretimi ve satışı ile ilgilenmektedir. Şirket, anti-tümör, anti-enfeksiyon, merkezi sinir sistemi hastalıkları, onkoloji, metabolik ve otoimmün hastalıklar vb. dahil olmak üzere terapötik alanlar için ürünler sunmaktadır.

Hansoh Pharmaceutical Group Company Limited Temel Bilgiler Özeti

Hansoh Pharmaceutical Group'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
3692 temel i̇stati̇sti̇kler
Piyasa değeriHK$101.83b
Kazançlar(TTM)HK$5.07b
Gelir(TTM)HK$13.00b

20.9x

F/K Oranı

8.2x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
3692 gelir tablosu (TTM)
GelirCN¥12.10b
Gelir MaliyetiCN¥1.09b
Brüt KârCN¥11.01b
Diğer GiderlerCN¥6.30b
KazançlarCN¥4.71b

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.79
Brüt Marj91.01%
Net Kâr Marjı38.97%
Borç/Özkaynak Oranı0.1%

3692 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

2.2%

Mevcut Temettü Verimi

40%

Ödeme Oranı